Location History:
- Hull, EN (1977)
- Hessle, GB (1979 - 1980)
Company Filing History:
Years Active: 1977-1980
Title: The Innovative Contributions of Barry A. Morgan
Introduction
Barry A. Morgan is a notable inventor based in Hessle, GB, recognized for his significant contributions to the field of pharmacology. With a total of three patents to his name, Morgan has made strides in developing compounds that exhibit pharmacological activity, particularly in relation to opiate receptor sites.
Latest Patents
Morgan's latest patents include the development of tetrapeptide amides, which are characterized by specific substituent groups. These compounds have shown pharmacological activity when tested in the transmurally stimulating guinea pig ileum preparation, indicating their affinity for opiate receptor sites. This suggests potential applications in treating conditions where an opiate-like effect is beneficial. Additionally, he has worked on tetrapeptide derivatives that also demonstrate pharmacological activity, both in vitro and in vivo, indicating their analgesic effects and utility as analgesic agents.
Career Highlights
Barry A. Morgan is associated with Reckitt & Colman Products Limited, where he has been able to apply his innovative ideas in a corporate setting. His work has contributed to advancements in the pharmaceutical industry, particularly in the development of new analgesic compounds.
Collaborations
Throughout his career, Morgan has collaborated with notable colleagues such as Derek J. Schafer and Michael J. Rance. These collaborations have likely enhanced the research and development of his patented compounds.
Conclusion
In summary, Barry A. Morgan's work in developing tetrapeptide amides and derivatives has significant implications for pharmacology and pain management. His contributions continue to influence the field and demonstrate the importance of innovation in medical science.